Literature DB >> 9452189

The progression of beta-amyloid deposition in the frontal cortex of the aged canine.

T Satou1, B J Cummings, E Head, K A Nielson, F F Hahn, N W Milgram, P Velazquez, D H Cribbs, A J Tenner, C W Cotman.   

Abstract

Brains from 41 aged canines (> or = 10 years of age) were examined immunohistochemically to characterize the laminar distribution and age-related progression of beta-amyloid (A beta) in frontal cortex. We classified the A beta patterns into four distinct types. Type I was characterized by small, faint deposits of A beta in deep cortical layers. Type II consisted of diffuse deposits of A beta mainly in layers V and VI. Type III had both dense plaques in superficial layers, and diffuse deposits in deep layers. Finally, Type IV had solely dense plaques throughout all layers of cortex. We compared the A beta distribution pattern between the Old canines (10-15 years, n = 22) and the Very Old canines (> 15 years, n = 19). The Old group primarily had negative staining, or Type I and Type II patterns of amyloid deposition (73%). Conversely, the Very Old group had predominantly Types II, III and IV deposits (89.5%), a difference that was significant (P < 0.05). We suggest that A beta deposition in canine frontal cortex is a progressive age-related process beginning with diffuse deposits in the deep cortical layers followed by the development of deposits in outer layers. In support of this hypothesis, the deeper layer diffuse plaques in the Very Old group of dogs also contain the largest proportion of beta-amyloid with an isomerized aspartic acid residue at position 7, indicating that these deposits had been present for some time. We also observed fiber-like A beta immunoreactivity within regions of diffuse A beta deposits. These fibers appeared to be degenerating neurites, which were negative for hyperphosphorylated tau. Therefore, these fibers may represent a very early form of neuritic change that precede tau hyperphosphorylation or develop by an alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9452189     DOI: 10.1016/s0006-8993(97)81684-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Rhinal and dorsolateral prefrontal cortex lesions produce selective impairments in object and spatial learning and memory in canines.

Authors:  Lori-Ann Christie; Richard C Saunders; Danuta M Kowalska; William A MacKay; Elizabeth Head; Carl W Cotman
Journal:  J Comp Neurol       Date:  2008-11-10       Impact factor: 3.215

Review 2.  Recent rodent models for Alzheimer's disease: clinical implications and basic research.

Authors:  Nady Braidy; Pablo Muñoz; Adrian G Palacios; Gloria Castellano-Gonzalez; Nibaldo C Inestrosa; Roger S Chung; Perminder Sachdev; Gilles J Guillemin
Journal:  J Neural Transm (Vienna)       Date:  2011-11-16       Impact factor: 3.575

3.  Neurobiology of the aging dog.

Authors:  Elizabeth Head
Journal:  Age (Dordr)       Date:  2010-09-16

Review 4.  Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review.

Authors:  Aswir Abd Rashed; Ahmad Zuhairi Abd Rahman; Devi Nair Gunasegavan Rathi
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

5.  Synergistic effects of long-term antioxidant diet and behavioral enrichment on beta-amyloid load and non-amyloidogenic processing in aged canines.

Authors:  Viorela Pop; Elizabeth Head; Mary-Ann Hill; Dan Gillen; Nicole C Berchtold; Bruce A Muggenburg; Norton W Milgram; M Paul Murphy; Carl W Cotman
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

6.  Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines.

Authors:  Elizabeth Head; Viorela Pop; Floyd Sarsoza; Rakez Kayed; Tina L Beckett; Christa M Studzinski; Jennifer L Tomic; Charles G Glabe; M Paul Murphy
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.

Authors:  Mark D Meadowcroft; James R Connor; Michael B Smith; Qing X Yang
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

8.  Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.

Authors:  Joseph A Araujo; Christa M Studzinski; Elizabeth Head; Carl W Cotman; Norton W Milgram
Journal:  Age (Dordr)       Date:  2005-05-02

Review 9.  Alzheimer's disease and the amyloid-beta peptide.

Authors:  M Paul Murphy; Harry LeVine
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.